ARDX vs JAZZ · rev $215.3M vs P/E 1988, rev $2.28B
Ardelyx Inc (ARDX) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ARDX currently screens at market cap $1.37B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ARDX and JAZZ stock pages for the full models.
Not investment advice.